Use fundamental data analysis to confirm all available indicators of Virtus LifeSci Biotech to find out if markets are presently mispricing the entity. We found ten available drivers for Virtus LifeSci Biotech Clinical Trls ETF which can be compared to its competition. Please use Virtus LifeSci Total Asset, and the relationship between Price to Sales and Three Year Return to make a decision on weather Virtus LifeSci Biotech is priced fairly. Use Virtus LifeSci to protect against small markets fluctuations. The etf experiences normal downward trend and little activity. Check odds of Virtus LifeSci to be traded at $24.23 in 30 days
Virtus LifeSci Company Summary
Virtus LifeSci competes with iShares Nasdaq, First Trust, PowerShares Dynamic, SPDR SP, and Principal Healthcare. The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Virtus LifeSci is traded on Archipelago Exchange in USA.
Virtus LifeSci Net Asset vs Price to Sales
Virtus LifeSci Biotech Clinical Trls ETF is rated below average in net asset as compared to similar ETFs. It is rated below average in price to sales as compared to similar ETFs . The ratio of Net Asset to Price to Sales for Virtus LifeSci Biotech Clinical Trls ETF is about 17,241,206
Virtus LifeSci Biotech Systematic Risk